PestleMedicine Explained

Vibegron

Obgemsa is a bladder muscle relaxant that reduces the activity of an overactive bladder. It is used in adults to treat symptoms such as a sudden need to empty the bladder, needing to empty it more often than usual, and not being able to control when to empty it, which leads to wetting yourself.

Active ingredient: vibegron

Official leaflet

Key facts

  1. The usual dose is 1 tablet per day, with or without food.
  2. Tell your doctor straight away if you are unable to empty your bladder (urinary retention).
  3. Do not take it if you are pregnant or think you may be pregnant, and do not breast-feed while taking it.
  4. Do not stop taking it early or when your symptoms improve, as your symptoms may return. Talk to your doctor before you stop.
  5. This medicine is subject to additional monitoring, so please report any side effects you get.

Who should not take vibegron

The leaflet says not to take it if any of these apply to you.

  • if you are allergic to vibegron or any of the other ingredients of this medicine

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • if you have trouble emptying your bladder or you have a weak urine stream
  • if you are taking any other medicines for overactive bladder syndrome, such as anticholinergic medicines for example oxybutynin, diphenhydramine, solifenacin
  • if you have severe liver problems or end-stage kidney disease, as Obgemsa should not be used in these cases
  • Do not give to children and adolescents under 18 years, as safety and efficacy have not been established

How to take vibegron

  • Take 1 tablet per day, exactly as your doctor has told you.
  • Swallow the tablet with a glass of water. If needed, you can crush it and mix it with 1 tablespoon (about 15 mL) of soft food such as applesauce, eat it immediately, then drink a glass of water.
  • You may take the tablet with or without food.
  • If you miss a dose, take the next dose as normal the next day and do not take a double dose. If you miss several doses, tell your doctor.
  • Do not stop taking it early, even if you see no immediate effect, as your bladder may need time to adapt.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • Inability to empty your bladder (urinary retention) (uncommon): tell your doctor straight away

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Common

Up to 1 in 10 people

  • headache
  • diarrhoea
  • nausea (feeling sick)
  • constipation
  • urinary tract infection (infection of structures that carry urine)
  • residual urine volume increased (an increase in the amount of urine left in the bladder after a voluntary urination)

Uncommon

Up to 1 in 100 people

  • urinary retention (inability to empty your bladder)
  • hot flush
  • urinary retention, including urinary straining (inability to empty your bladder)
  • rash (including itchy rash, and red rash)

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

Do not take Obgemsa if you are pregnant, think you may be pregnant or are planning to have a baby, as it is not known how it will affect the baby. It is likely to pass into breast milk and the risks for the baby are unknown, so you should not breast-feed while taking it.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • any other medicines you are taking, have recently taken or might take
  • other medicines for overactive bladder, such as anticholinergic medicines (for example oxybutynin, diphenhydramine, solifenacin)
  • digoxin (a medicine for heart failure or abnormal heart rhythm)
  • dabigatran etexilate (an anticoagulant)
  • apixaban (an anticoagulant)
  • rivaroxaban (an antithrombotic)

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Obgemsa 75 mg Film-Coated Tablets
Product licence
PLPI335430434
Leaflet dated
Checked against the leaflet
Automated check
10 of 10 side effects matched to the wording of the leaflet

Other makers of vibegron publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.